Navigation Links
ePharmaSolutions' Clinical Trial Investigator Portal Wins Bio-IT World 2009 Best Practice Award
Date:4/30/2009

CONSHOHOCKEN, Pa., April 30 /PRNewswire/ -- ePharmaSolutions, a leading provider of clinical services and trial management technologies for the biopharmaceutical industry announced that it has been selected along with its client Genentech, Inc as the winner of the Bio-IT World Best Practice Award for it's Clinical Trial Portal solution. Winners were selected from 72 submissions in 7 categories by a peer reviewed panel of 14 expert judges. The ePharmaSolutions Clinical Trial Portal Solution won in the Clinical Trials Management category.

"We are absolutely thrilled that our application is recognized as the most innovative clinical trial management solution by such a distinguished panel of judges," stated Lance Converse, Founder and CEO of ePharmaSolutions. "We have worked exceptionally hard to develop solutions that help solve some of the industries biggest causes of study delays. This award validates our mission and strategy to provide to the industry with best in class solutions that facilitates ongoing communication and collaboration between all of the stakeholders in the clinical trial process," added Converse.

The Clinical Trial Portal was developed to provide pharmaceutical companies with a common technology platform to streamline and accelerate site selection, activation, training, patient recruitment and communication. In addition, the Clinical Trial Portal uses a federated user identity management model that provides users with one set of credentials across all sponsors to help reduce the amount of userIDs and passcodes that are typically required in this industry. The Clinical Trial Portal currently hosts 143,000 active clinical research users from 107 countries for the top 20 pharmaceutical companies in the world.

"To be selected along side such companies as Wyeth, GSK, Merck, Abbott and AstraZeneca is truly an honor," said Enrico DePaolis, President & Chief Operating Officer for ePharmaSolutions. "Our teams have been working exceptionally hard to develop solutions that meet our client needs, while ensuring they are simple and easy for sites to adopt and use. The credit really should go to them," added DePaolis.

In today's technology-driven clinical trials environment, sponsors and sites are required to use dozens of new technologies for every study they conduct, typically having to remember different user credentials for each technology. The Clinical Trial Portal helps streamline and systematize clinical trial workflow between sponsors and sites providing one userID and one URL for all of the studies they conduct while providing detailed and dashboard level reporting to help manage the entire process at the user, site, study and enterprise level.

About ePharmaSolutions, Inc.

ePharmaSolutions is a leading provider of technology-based clinical services that help improve the way sites are selected, trained, activated and supported to commence clinical trials and meet enrollment goals. ePharmaSolutions has activated and trained more than 143,000 clinical researchers in 107 countries for the top 20 pharmaceutical companies in the world. ePharmaSolutions is headquartered in Philadelphia, Pennsylvania. For more information call 610-832-9915 or visit www.epharmasolutions.com. For an interactive demonstration of the Clinical Trial Portal go to http://courses.epharmasolutions.com/diasomedemo/shortdemo.htm.


'/>"/>
SOURCE ePharmaSolutions
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... 27, 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ... whatever measures required to build a strong and stable ... currently listed on the OTC Markets-pink current trading platform. ... CEO, "We are seeing an anomaly in market trading ... only by the Company, but shareholders and market players ...
(Date:6/24/2016)... , June 24, 2016  Consumers have ... and regulators/payers have placed more emphasis on patient ... patient support programs in the pharmaceutical industry have ... medications. Consequently, pharmaceutical companies are focusing on becoming ... are providing products and services that improve health. ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
Breaking Medicine News(10 mins):